Literature DB >> 3459602

Magnetic resonance imaging of osteosarcomas. Comparison with computed tomography.

W D Zimmer, T H Berquist, R A McLeod, F H Sim, D J Pritchard, T C Shives, L E Wold, G R May.   

Abstract

This study was done to describe the magnetic resonance imaging (MRI) characteristics of osteosarcomas and to determine the clinical usefulness of MRI in the evaluation of patients with these tumors. Ten patients with osteosarcomas were examined with a Picker MRI scanner (0.15 Tesla resistive magnet). All had computed tomograms available for comparison. For demonstrating tumor extent in marrow, MRI was superior to computed tomography (CT) in 60% and about equal to CT in 40%. For defining soft tissue mass, MRI was superior to CT in 40% and about equal to CT in 60%. Direct sagittal and coronal images on MRI and superior contrast differences between tumor and normal tissues with MRI were the reasons for the advantage of MRI in these instances. CT was superior in all cases for demonstrating calcifications. Overall, MRI is better than CT for defining local extent of osteosarcomas. It is of greatest value in the peripheral skeleton, in the medullary canal, and in soft tissues.

Entities:  

Mesh:

Year:  1986        PMID: 3459602

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Femur mass in a 43-year-old woman.

Authors:  Yan Epelboym; Kapil R Desai; Roberto Garcia; James C Wittig
Journal:  Clin Orthop Relat Res       Date:  2012-05-12       Impact factor: 4.176

2.  Scintigraphic evaluation of tumor regression during preoperative chemotherapy of osteosarcoma. Correlation of 99mTc-methylene diphosphonate parametric imaging with surgical histopathology.

Authors:  J Knop; G Delling; U Heise; K Winkler
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

3.  Manual and semiautomatic segmentation of bone sarcomas on MRI have high similarity.

Authors:  F C F Dionísio; L S Oliveira; M A Hernandes; E E Engel; R M Rangayyan; P M Azevedo-Marques; M H Nogueira-Barbosa
Journal:  Braz J Med Biol Res       Date:  2020-01-31       Impact factor: 2.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.